Real R&D cost much lower than what pharma cos claim

[Guest guest]

http://articles.timesofindia.indiatimes.com/2011-03-14/india-business/28687649_1_r-d-cost-study-of-drug-development-clinical-trials

Real R & D cost much lower

than what pharma cos claim

Rema Nagarajan, TNN, Mar 14, 2011, 12.47am

IST

NEW DELHI: Talk to a drug industry executive about high

medicine prices and they throw back the $1.3 billion the

industry spends on average on research and development

(R & D) of a single drug. In a recent analysis bound to

deflate this justification for high pricing, two health

economists have demonstrated how the real R & D cost for a

new drug could be just 5-15% of the touted $1.3 billion.

The analysis concludes that the real R & D cost for a drug

borne by a pharmaceutical company is probably about $60

million. This latest analysis has been done by W Light

of Stanford

University and Warburton of the University of

in Canada.

The analysis has been published as an article,

'Demythologizing the high costs of pharmaceutical research' in

the latest issue of Biosocieties, a quarterly social sciences

journal of the London

School of Economics and Political Science.

[Guest guest]

http://articles.timesofindia.indiatimes.com/2011-03-14/india-business/28687649_1_r-d-cost-study-of-drug-development-clinical-trials

Real R & D cost much lower

than what pharma cos claim

Rema Nagarajan, TNN, Mar 14, 2011, 12.47am

IST

NEW DELHI: Talk to a drug industry executive about high

medicine prices and they throw back the $1.3 billion the

industry spends on average on research and development

(R & D) of a single drug. In a recent analysis bound to

deflate this justification for high pricing, two health

economists have demonstrated how the real R & D cost for a

new drug could be just 5-15% of the touted $1.3 billion.

The analysis concludes that the real R & D cost for a drug

borne by a pharmaceutical company is probably about $60

million. This latest analysis has been done by W Light

of Stanford

University and Warburton of the University of

in Canada.

The analysis has been published as an article,

'Demythologizing the high costs of pharmaceutical research' in

the latest issue of Biosocieties, a quarterly social sciences

journal of the London

School of Economics and Political Science.

[Guest guest]

http://articles.timesofindia.indiatimes.com/2011-03-14/india-business/28687649_1_r-d-cost-study-of-drug-development-clinical-trials

Real R & D cost much lower

than what pharma cos claim

Rema Nagarajan, TNN, Mar 14, 2011, 12.47am

IST

NEW DELHI: Talk to a drug industry executive about high

medicine prices and they throw back the $1.3 billion the

industry spends on average on research and development

(R & D) of a single drug. In a recent analysis bound to

deflate this justification for high pricing, two health

economists have demonstrated how the real R & D cost for a

new drug could be just 5-15% of the touted $1.3 billion.

The analysis concludes that the real R & D cost for a drug

borne by a pharmaceutical company is probably about $60

million. This latest analysis has been done by W Light

of Stanford

University and Warburton of the University of

in Canada.

The analysis has been published as an article,

'Demythologizing the high costs of pharmaceutical research' in

the latest issue of Biosocieties, a quarterly social sciences

journal of the London

School of Economics and Political Science.

[Guest guest]

http://articles.timesofindia.indiatimes.com/2011-03-14/india-business/28687649_1_r-d-cost-study-of-drug-development-clinical-trials

Real R & D cost much lower

than what pharma cos claim

Rema Nagarajan, TNN, Mar 14, 2011, 12.47am

IST

NEW DELHI: Talk to a drug industry executive about high

medicine prices and they throw back the $1.3 billion the

industry spends on average on research and development

(R & D) of a single drug. In a recent analysis bound to

deflate this justification for high pricing, two health

economists have demonstrated how the real R & D cost for a

new drug could be just 5-15% of the touted $1.3 billion.

The analysis concludes that the real R & D cost for a drug

borne by a pharmaceutical company is probably about $60

million. This latest analysis has been done by W Light

of Stanford

University and Warburton of the University of

in Canada.

The analysis has been published as an article,

'Demythologizing the high costs of pharmaceutical research' in

the latest issue of Biosocieties, a quarterly social sciences

journal of the London

School of Economics and Political Science.